A detailed history of Royal Bank Of Canada transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 17,810 shares of SANA stock, worth $46,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,810
Previous 12,835 38.76%
Holding current value
$46,484
Previous $70,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.76 - $6.86 $18,706 - $34,128
4,975 Added 38.76%
17,810 $74,000
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $30,156 - $60,197
5,766 Added 81.57%
12,835 $70,000
Q1 2024

Nov 05, 2024

SELL
$4.2 - $11.27 $24,217 - $64,982
-5,766 Reduced 44.92%
7,069 $70,000
Q1 2024

May 15, 2024

SELL
$4.2 - $11.27 $102,559 - $275,202
-24,419 Reduced 77.55%
7,069 $70,000
Q4 2023

Feb 14, 2024

BUY
$2.8 - $4.55 $43,461 - $70,625
15,522 Added 97.22%
31,488 $128,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $23,483 - $38,806
6,229 Added 63.97%
15,966 $61,000
Q2 2023

Aug 14, 2023

BUY
$3.22 - $7.53 $13,385 - $31,302
4,157 Added 74.5%
9,737 $58,000
Q1 2023

May 15, 2023

SELL
$3.11 - $4.92 $18,737 - $29,643
-6,025 Reduced 51.92%
5,580 $18,000
Q4 2022

Feb 14, 2023

BUY
$3.19 - $6.46 $32,522 - $65,859
10,195 Added 723.05%
11,605 $45,000
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $3,119 - $5,053
559 Added 65.69%
1,410 $9,000
Q2 2022

Aug 15, 2022

SELL
$4.12 - $9.35 $19,586 - $44,449
-4,754 Reduced 84.82%
851 $5,000
Q1 2022

May 16, 2022

SELL
$5.24 - $15.58 $77,955 - $231,783
-14,877 Reduced 72.63%
5,605 $46,000
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $157,522 - $240,227
10,377 Added 102.69%
20,482 $317,000
Q3 2021

Nov 15, 2021

BUY
$16.29 - $25.88 $131,395 - $208,748
8,066 Added 395.59%
10,105 $227,000
Q2 2021

Aug 16, 2021

BUY
$16.65 - $32.14 $33,949 - $65,533
2,039 New
2,039 $40,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $497M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.